Shares of Vital Farms advanced 5.4% to $11.15 in morning trading on Monday, extending gains after a Wall Street analyst upgraded the stock to 'buy' amid signs of stabilization in the U.S. egg market.
The upgrade from Benchmark follows a strategic decision by Vital Farms to exit its butter operations, redirecting resources toward its core pasture-raised egg business. The company reported second-quarter results on August 6, with revenue slightly exceeding analyst expectations despite a year-over-year decline. Management maintained its full-year revenue guidance of $775 million to $800 million.
Benchmark cited improving industry conditions, including a gradual reduction in oversupply that had pressured margins across the egg sector. The analyst also highlighted Vital Farms' recent inclusion in the Russell 2000 Value and Russell 2500 Value indexes, which may attract passive fund inflows.
Vital Farms' 52-week range stands at $7.95 to $53.13. The broader market showed mixed performance, with the NASDAQ down 0.5% and the S&P 500 down 0.2%. The company continues to operate in a challenging environment marked by compressed margins and ongoing litigation.
